Publication
Cancer-specific mortality in high-risk or very high-risk prostate cancer patients treated with cryotherapy vs. external beam radiation therapy.
Leonardo Quarta, Michele Petix, Maximilian Filzmayer, Filippo Orlandi, Jordan A Goyal, Matteo Ferro, Felix K H Chun, Salvatore Micali, Shahrokh F Shariat, Mohamed Abouelenein, Francesco Barletta, Armando Stabile, Giorgio Gandaglia, Francesco Montorsi, Fred Saad, Alberto Briganti, Pierre I Karakiewicz
- Source
- PubMed
- Retrieved
- Sep 26, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260926-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
INTRODUCTION: Cryotherapy in high-risk or very high-risk prostate cancer (PCa) is not guidelines recommended, but it is occasionally used outside of formal clinical trials. However, its effect on cancer-specific mortality (CSM) relatively to standard treatment options such as external beam…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Prostate Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available